Navigation Links
Improving clinical use of stem cells to repair heart damage
Date:7/13/2010

Presenting at the UK National Stem Cell Network annual science conference today (13 July), Professor Michael Schneider describes a new approach to treating heart attack and cardiomyopathy using stem cells.

Professor Schneider, British Heart Foundation Professor at Imperial College London, said "Recent clinical trials using stem cells to treat heart damage have been successful in terms of safety but unfortunately the bone marrow stem cells used tend to give only a small improvement in how well the heart is pumping.

"We really want to use stem cells from the patients themselves that we know can give rise to beating heart cells and these are not found in bone marrow. The good news is that we're now finding ways to identify and purify such cells."

Around 1000 patients have been treated in approximately 20 trials worldwide, mostly using bone marrow stem cells or derivatives of bone marrow cells to repair damage caused by heart attack. There has also been a significant body of work looking at ways of producing beating heart cells from stem cells. The best proven approaches to creating new beating heart cells are using embryonic stem cells, induced pluripotent cells and heart-derived stem cells.

Professor Schneider continued: "Using heart-derived stem cells to treat heart attack and cardiomyopathy has some advantages over embryonic and induced pluripotent cells as they are potentially safer. It's also notable that of these three cell types, it's only heart-derived cells that are in current human clinical trials for this sort of treatment.

"The biggest challenge is to make an ideal product for transplant, which would be either a mixture of heart muscle- and blood vessel-forming cells or a pure population of some sort of precursor that could give rise to both muscle and blood vessel cells."

Professor Schneider's team have discovered a way to identify heart stem cells so as to purify them for transplant. They first developed the method in mice and although the identifying markers are quite different in human cells, they have been able to successfully map their knowledge from mice onto humans. This research is funded by the British Heart Foundation, the European Research Council, the European Union (through the EU FP7 CardioCell consortium), the Leducq Foundation and the Medical Research Council.

Professor Schneider said "We've developed a method to identify cells that have three important characteristics: They are definitely stem cells; they have the right molecular machinery turned on in order to become heart muscle or blood vessel; and they don't yet have any of the full characteristics of heart muscle or blood vessel cells such as producing cardiac myosin - an important protein in heart muscle cells."

The next stage of the research is to develop this technique into a method for extracting, purifying and multiplying heart stem cells in the clinic to be used to repair heart damage arising from heart attack or cardiomyopathy. Professor Schneider's laboratory uses advanced robotics, automated microscopy and other high-throughput methods to screen many thousands of experimental conditions in order to devise the best ways to grow the cells and instruct them to go down the route of becoming heart muscle.


'/>"/>

Contact: Nancy Mendoza
ukpo@uknscn.org
01-793-413-355
Biotechnology and Biological Sciences Research Council
Source:Eurekalert

Related biology news :

1. Algae advances as a green alternative for improving water quality
2. Inventor honored for tech improving access to clean water, healthcare, and business development in India
3. Lengthening time a drug remains bound to a target may lead to improving diagnostics, therapy
4. Improving the degradation of toxic hydrocarbons
5. New patented technology for improving cardiac CTs receives NIH support
6. Improving the odds
7. Improving livestock productivity in Honduras
8. Greatest thing since sliced bread: New data offer important clues toward improving wheat yields
9. High blood sugars impact on immune system holds clues to improving islet cell transplants
10. Pioneering Use of Mobile Technology to Conduct Clinical Trials in Emerging Economies
11. Announcing the 1st IOF-ESCEO Pre-Clinical Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... April 19, 2017 The global ... landscape is marked by the presence of several large ... held by five major players - 3M Cogent, NEC ... accounted for nearly 61% of the global military biometric ... in the global military biometrics market boast global presence, ...
(Date:4/13/2017)... SANTA MONICA, Calif. , April 13, 2017 /PRNewswire/ ... New York will feature emerging and ... Innovation Summits. Both Innovation Summits will run alongside the ... variety of speaker sessions, panels and demonstrations focused on ... east coast,s largest advanced design and manufacturing event will ...
(Date:4/11/2017)... , Apr. 11, 2017 Research and Markets ... 2017-2021" report to their offering. ... The global eye tracking market to grow at a CAGR ... Global Eye Tracking Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
Breaking Biology News(10 mins):
(Date:9/14/2017)... ... September 14, 2017 , ... ... program (FSP)-- a flexible business approach similar to a full-time equivalent program ... project-based analytical and solid-state chemistry services and expertise with flexible extended research ...
(Date:9/14/2017)... ... September 14, 2017 , ... ... launch of its CliniControlâ„¢ (CC) product portfolio, clinically-relevant starting and ancillary materials ... of human Mesenchymal Stem/Stromal Cell (hMSC)-based therapies. The CliniControl product portfolio will ...
(Date:9/14/2017)... ... September 14, 2017 , ... AxioMed is pleased to announce ... Steven Yang completed the procedure on a 35-year-old female patient suffering from degenerative ... at level L5-S1. The patient failed conservative treatments prior to undergoing surgery. , ...
(Date:9/14/2017)... ... , ... AIM Global, the worldwide standards agency for AIDC and barcode technology ... Study Competition for AIDC. The award is given to those in the industry ... adoption of automated data collection systems further. The TRACTUS platform, by Matrix, is ...
Breaking Biology Technology: